Drug Shortage Report for JENTADUETO
Report ID | 124840 |
Drug Identification Number | 02403269 |
Brand name | JENTADUETO |
Common or Proper name | Jentadueto 2.5/850mg 6x10 |
Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
Market Status | MARKETED |
Active Ingredient(s) | LINAGLIPTIN METFORMIN HYDROCHLORIDE |
Strength(s) | 2.5MG 850MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | Blister Pack 6x10 |
ATC code | A10BD |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-10-05 |
Actual start date | 2020-10-05 |
Estimated end date | 2021-03-12 |
Actual end date | 2021-03-11 |
Shortage status | Resolved |
Updated date | 2021-03-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2020-09-22 | French | Compare |
v1 | 2020-09-22 | English | Compare |